Meet Dr Jeff Trickett, Director Business Development, to discuss your clinical pharmacology and clinical development needs at Outsourcing in Clinical Trials Southern California, 25 September 2019.
If you missed our live webinar, Scintigraphy - Providing Critical Data in Early Clinical Development, you can view on demand now. Watch this 1-hour webinar if you are embarking on your clinical development plan, consider a non-invasive in vivo evaluation of drug delivery systems. Scintigraphy gives you the power to study drugs in gastrointestinal organs, providing you [...]
We offer specialist expertise in healthy volunteer studies, oncology, rare & orphan diseases, respiratory and infectious vaccines & diseases, with our team of experts available to discuss your clinical development plans at BIO 2019. We have expertise in all drug types, dosage forms and delivery mechanisms, and can further support your development programme with our [...]
If you missed our live webinar, Agility for Rare Disease and Oncology Clinical Trials - Data Management, you can view on demand now. Watch this 1-hour webinar to review strategies for data management in modular and adaptive clinical trials. Modular and adaptive clinical trials are rapidly expanding the ability of researchers to modify clinical trials [...]
Meet Dr Simon Hutchings, Director of Scientific Affairs at Outsourcing Clinical Trials West Coast, February 12 & 13 2019. Find out how we can add value and reduce risk with your protocol development Discover why our purpose-built clinical pharmacology unit attracts US drug developers Discover how adaptive clinical trial design can accelerate early clinical development
If you missed our live ESMO Update: State of the Art in Early Phase Oncology Trial Design webinar you can view on demand now. The science looks promising and you have secured vital funding to take your compound to the clinical stage. What is the best strategy for operationalizing your oncology study in a clinical setting to meet your [...]
Join us at the British Embassy in Geneva, to discuss Rare Disease & Oncology therapy Clinical Development plans to improve your Net Present Value (NPV). Read the programme and register here.
Ronald Openshaw, Chief Executive Officer, Simbec-Orion Group Doulgas Cookson, SVP Commercial Development, Simbec-Orion Group Ceri Edwards, Associate Managing Director, Simbec Research Alain Thibault, Senior Medical Director, Orion Clinical
If you missed our live Orphan Drug Designation (ODD) webinar you can view on demand now. Achieving ODD status, is a significant step enabling your product to be licensed faster, cost-efficiently, and achieve market exclusivity for 10 years. Join this 1-hour webinar where the audience will gain a practical overview in the steps to achieve [...]
Meet the team Douglas Cookson, SVP Commercial Development, Simbec-Orion Group Dani Hristova, Associate Medical Director, Orion Clinical Jeff Trickett, Director Business Development, Simbec-Orion Group Steve Novak, Director Business Development, Simbec-Orion Group